# OnCo record idea-pu-prostate-hypofractionation-default (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-pu-prostate-hypofractionation-default/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-pu-prostate-hypofractionation-default" ;
  schema:name "Four weeks or five treatments, not seven and a half weeks, for prostate radiotherapy"@en ;
  schema:description "Randomised trials showed that 20 treatments over four weeks, and for many men five, control localised prostate cancer as well as 37 to 39, and England's national guideline has offered the four-week course since 2019. In New South Wales its use rose from 5.2 to 40.3 per cent of men between 2014 and 2018, and an international survey found it used less for high-risk disease."@en ;
  schema:url <https://onco.cc/ideas/idea-pu-prostate-hypofractionation-default/> ;
  schema:dateModified "2026-10-20"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(16)30102-4>, <https://doi.org/10.1056/NEJMoa2403365>, <https://www.nice.org.uk/guidance/ng131/chapter/Recommendations>, <https://doi.org/10.1016/j.ijrobp.2021.04.033>, <https://doi.org/10.1200/go.23.00046> ;
  onco:tag "protocol-upgrade", "upgrade:proven-unevenly-used", "evidence:strong" ;
  onco:related <https://onco.cc/ideas/idea-acc-hypofractionation-default-lmic/>, <https://onco.cc/ideas/idea-cost-hypofractionation-payment/>, <https://onco.cc/ideas/idea-pu-five-fraction-breast-default/>, <https://onco.cc/ideas/idea-pu-rectal-spacer-prostate/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:institutions <https://onco.cc/institutions/nice/> ;
  onco:terms <https://onco.cc/terms/hypofractionation/>, <https://onco.cc/terms/prostate-radiotherapy-fractionation/> ;
  onco:trials <https://onco.cc/trials/chhip/>, <https://onco.cc/trials/pace-b/>, <https://onco.cc/trials/hypo-rt-pc/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-knowledge-diffusion/>, <https://onco.cc/bottlenecks/b-incentive-misalignment/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-chhip-lancet-oncol-2016/>, <https://onco.cc/key-papers/paper-van-as-n-engl-j-med/>, <https://onco.cc/key-papers/paper-widmark-lancet/> .